Matthew Begley

Title: Innovations of Matthew Begley in Dengue Virus Research

Introduction

Matthew Begley is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of virology, particularly in the study of dengue virus serotypes. His innovative work has led to the development of a patent that addresses critical aspects of dengue virus research.

Latest Patents

Matthew Begley holds a patent for "Methods and compositions for dengue virus serotype 4 epitopes." This invention provides compositions and methods of use that comprise a chimeric dengue virus E glycoprotein. The glycoprotein backbone includes amino acid substitutions that introduce a dengue virus E glycoprotein epitope from a different dengue virus serotype. This innovative approach has the potential to enhance the understanding and treatment of dengue virus infections.

Career Highlights

Matthew Begley is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work has garnered attention for its potential impact on public health, particularly in regions affected by dengue fever. With 1 patent to his name, he continues to push the boundaries of scientific research in virology.

Collaborations

Throughout his career, Matthew has collaborated with notable researchers, including Ralph Baric and Usha Nivarthi. These collaborations have enriched his research and contributed to advancements in the understanding of dengue virus.

Conclusion

Matthew Begley's innovative work in dengue virus research exemplifies the importance of scientific inquiry in addressing global health challenges. His contributions through patents and collaborations highlight the ongoing efforts to combat infectious diseases.